SP Medical Journal

Q: 如果SP Medical Journal在你的國家或地區不可用，應該如何下載？

點擊<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">此處</a>瞭解如何在受限國家或地區下載SP Medical Journal。

Q: 運行SP Medical Journal的最低配置要求是什麼？

以下為SP Medical Journal的最低配置要求。<br/><ul><li>iPhone-須使用 iOS 10.0 或以上版本。</li><li>iPad-須使用 iPadOS 10.0 或以上版本。</li><li>iPod touch-須使用 iOS 10.0 或以上版本。</li></ul>

免費

2.8for iPhone, iPad and more

Zeppelini

Developer

29.3 MB

Size

2019年12月14日

Update Date

Education

Category

Age Rating

App Store 開發者網站

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

SP Medical Journal 螢幕截圖

iPad

iPhone

About SP Medical Journal

The São Paulo Medical Journal/Evidence for Health Care was founded in 1932. Its articles are indexed in Medline, Lilacs, SciELO, Science Citation Index Expanded, Journal Citation Reports/Science Edition (ISI) and EBSCO Publishing.
Published bimonthly by the Associação Paulista de Medicina, the journal accepts articles in the fields of clinical health science (internal medicine, gynecology and obstetrics, mental health, surgery, pediatrics and public health). Articles will be accepted in the form of original articles (clinical trials, cohort, case-control, prevalence, incidence, accuracy and cost-effectiveness studies and systematic reviews with or without meta-analysis), narrative reviews of the literature, case reports, short communications and letters to the editor. Papers with a commercial
objective will not be accepted.